Citric Acid

Citric Acid

SCHEMBL73056

O=C([O-])CC(O)(CC(=O)O)C(=O)[O-].[H+].[Na+]

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1GSK3AGSK3BHRH1HRH2HTR7IDH1IDH2IMPA1IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA4 P22748 2/20 0.77
ALDH1A1 P00352 1/20 0.48
HMGCR P04035 1/20 0.37
CHRM1 P11229 1/20 0.37
TBXA2R P21731 1/20 0.37
ADRA1A P35348 1/20 0.37
ACLY P53396 3/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
CASP1 P29466 1/20 0.31
CPT2 P23786 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL6864505 0.98 CA4 (0.74) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL9004291 0.98 CA4 (0.81) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL43667 0.98 CA4 (0.81) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL475574 0.98 CA4 (0.73) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL28693270 0.98 CA4 (0.81) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL27897065 0.98 CA4 (0.81) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL107371 0.95 CA4 (0.70) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL4733350 0.95 CA4 (0.77) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL365961 0.95 CA4 (0.77) CA4ALDH1A1HMGCRCHRM1TBXA2R
Citric Acid SCHEMBL4362561 0.95 CA4 (0.77) CA4ALDH1A1HMGCRCHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 686 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3487916-B1 FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITION CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER SOLVAY (BE) 2025-09-03 EP claimed
CN-120059003-A Low-odor polyvinyl alcohol and preparation method and application thereof 中国石油化工股份有限公司 2025-05-30 CN claimed
CN-119465115-A Chemical thick copper-precipitating composite liquid and preparation method thereof 惠州金晟新电子科技有限公司 2025-02-18 CN claimed
CN-118834332-A Ionic hydrogel, preparation method thereof and application of ionic hydrogel in thermoelectric intelligent color-changing glass 华南理工大学 2024-10-25 CN claimed
CN-118806759-A Systemic formulations of pyridone derivatives for TG2 related diseases 福尔克博士药物有限责任公司 2024-10-22 CN claimed
CN-115867260-B Systemic formulations of pyridone derivatives for celiac disease 福尔克博士药物有限责任公司 2024-10-01 CN claimed
EP-3655469-B1 FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITION CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER SOLVAY (BE) 2024-09-25 EP claimed
CN-115715187-B Systemic formulations of pyridone derivatives for TG2 related diseases 福尔克博士药物有限责任公司 2024-07-19 CN claimed
EP-3556371-B1 PHARMACEUTICAL COMPOSITION OF SULFONYLUREA DRUGS AND PREPARATION METHOD THEREFOR JIANGSU AOSAIKANG PHARM CO LTD (CN) 2024-06-12 EP claimed
CN-118079003-A Phosphodiesterase type 5 inhibitors for lowering uric acid levels and uses thereof 海南大学 2024-05-28 CN claimed
US-5106534-A Polycarboxylic acid and inorganic carbonate surface treated with component which prevents water absorption J. M. HUBER CORPORATION (US) 1992-04-21 US claimed
WO-1991016893-A1 PHARMACEUTICAL FORMULATION BEECHAM GROUP PLC (GB) 1991-11-14 WO claimed
US-5045570-A Additives are caused to concentrate at the surface of the foamed article J. M. HUBER CORPORATION (US) 1991-09-03 US claimed
US-5037580-A Mixture of surface treated polycarboxylic acid and inorganic carbonate J. M. HUBER CORPORATION (US) 1991-08-06 US claimed
US-5009810-A Mixture of polycarboxylic acid and inorganic carbonate surface treated with silane coupling agent, monoglycerides or stearic acid; foaming polymers J. M. HUBER CORPORATION (US) 1991-04-23 US claimed
US-5009809-A High temperature endothermic blowing agents compositions and applications J. M. HUBER CORPORATION (US) 1991-04-23 US claimed
WO-1990014384-A1 ENDOTHERMIC BLOWING AGENTS COMPOSITIONS AND APPLICATIONS J.M. HUBER CORPORATION (US) 1990-11-29 WO claimed
EP-0396335-A1 Pharmaceutical formulation Beecham Group p.l.c. (GB) 1990-11-07 EP claimed
US-4961927-A Clear solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate EISAI CO., LTD. (JP) 1990-10-09 US claimed
US-4200586-A Inhibiting the carbon-carbon double bond isomerization of substituted or unsubstituted hydrocarbon compounds PHILLIPS PETROLEUM COMPANY (US) 1980-04-29 US claimed